SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-17-000030
Filing Date
2017-04-28
Accepted
2017-04-28 16:22:12
Documents
82
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2017q110-q.htm 10-Q 1256590
2 EXHIBIT 10.1 a2017q110-q_exhibit101.htm EX-10.1 510586
3 EXHIBIT 10.2 a2017q110-q_exhibit102.htm EX-10.2 645140
4 EXHIBIT 10.3 a2017q110-q_exhibit103.htm EX-10.3 39805
5 EXHIBIT 31.1 a2017q110-q_exhibit311.htm EX-31.1 14549
6 EXHIBIT 31.2 a2017q110-q_exhibit312.htm EX-31.2 14408
7 EXHIBIT 32.1 a2017q110-q_exhibit321.htm EX-32.1 11925
  Complete submission text file 0000875320-17-000030.txt   9270208

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT vrtx-20170331.xml EX-101.INS 1884614
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20170331.xsd EX-101.SCH 65261
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20170331_cal.xml EX-101.CAL 98406
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20170331_def.xml EX-101.DEF 346779
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20170331_lab.xml EX-101.LAB 782695
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20170331_pre.xml EX-101.PRE 486470
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 17795888
SIC: 2834 Pharmaceutical Preparations